These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2559064)

  • 1. Characterization and in vivo distribution of 99mTc- and 111In-labelled magnetite.
    Bligh SW; Sadler PJ; Marriott JA; Latham IA; Kelly JD
    Int J Rad Appl Instrum A; 1989; 40(9):751-7. PubMed ID: 2559064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study.
    Okon E; Pouliquen D; Okon P; Kovaleva ZV; Stepanova TP; Lavit SG; Kudryavtsev BN; Jallet P
    Lab Invest; 1994 Dec; 71(6):895-903. PubMed ID: 7807971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextran magnetite as a liver contrast agent.
    Magin RL; Bacic G; Niesman MR; Alameda JC; Wright SM; Swartz HM
    Magn Reson Med; 1991 Jul; 20(1):1-16. PubMed ID: 1943651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long circulating superparamagnetic particles with high T2 relaxivity.
    Pochon S; Hyacinthe R; Terrettaz J; Robert F; Schneider M; Tournier H
    Acta Radiol Suppl; 1997; 412():69-72. PubMed ID: 9240083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of superparamagnetic iron-oxide MR contrast agents in the rat.
    Majumdar S; Zoghbi SS; Gore JC
    Invest Radiol; 1990 Jul; 25(7):771-7. PubMed ID: 2391194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional NMR microscopy of rat spleen and liver.
    Zhou X; Magin RL; Alameda JC; Reynolds HA; Lauterbur PC
    Magn Reson Med; 1993 Jul; 30(1):92-7. PubMed ID: 7690447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and quantitation in rat tissues of the superparamagnetic magnetic resonance contrast agent dextran magnetite as demonstrated by electron spin resonance spectroscopy.
    Iannone A; Federico M; Tomasi A; Magin RL; Casasco A; Calligaro A; Vannini V
    Invest Radiol; 1992 Jun; 27(6):450-5. PubMed ID: 1376725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen.
    Mendonca Dias MH; Lauterbur PC
    Magn Reson Med; 1986 Apr; 3(2):328-30. PubMed ID: 3713497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.
    Briley-Saebo K; Bjørnerud A; Grant D; Ahlstrom H; Berg T; Kindberg GM
    Cell Tissue Res; 2004 Jun; 316(3):315-23. PubMed ID: 15103550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dipolar interaction in the quantitative determination of particulate magnetic carriers in biological tissues.
    López A; Gutiérrez L; Lázaro FJ
    Phys Med Biol; 2007 Aug; 52(16):5043-56. PubMed ID: 17671352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USPIO (Ferumoxtran-10)-enhanced MRI to visualize reticuloendothelial system cells in neonatal rats: feasibility and biodistribution study.
    Azoulay R; Olivier P; Baud O; Verney C; Santus R; Robert P; Gressens P; Sebag G
    J Magn Reson Imaging; 2008 Oct; 28(4):1046-52. PubMed ID: 18821607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution of ultrasmall iron oxide particles in the rat liver.
    Van Beers BE; Sempoux C; Materne R; Delos M; Smith AM
    J Magn Reson Imaging; 2001 Apr; 13(4):594-9. PubMed ID: 11276104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of iron oxide nanoparticles in rat lymph nodes studied using electron energy loss spectroscopy (EELS) and electron spectroscopic imaging (ESI).
    Bordat C; Sich M; Réty F; Bouet O; Cournot G; Cuénod CA; Clément O
    J Magn Reson Imaging; 2000 Sep; 12(3):505-9. PubMed ID: 10992320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents.
    Reimer P; Kwong KK; Weisskoff R; Cohen MS; Brady TJ; Weissleder R
    J Magn Reson Imaging; 1992; 2(2):177-81. PubMed ID: 1562768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
    Weissleder R; Elizondo G; Wittenberg J; Rabito CA; Bengele HH; Josephson L
    Radiology; 1990 May; 175(2):489-93. PubMed ID: 2326474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferromagnetic contrast agents: a new approach.
    Renshaw PF; Owen CS; McLaughlin AC; Frey TG; Leigh JS
    Magn Reson Med; 1986 Apr; 3(2):217-25. PubMed ID: 3713487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetite albumin microspheres: a new MR contrast material.
    Widder DJ; Greif WL; Widder KJ; Edelman RR; Brady TJ
    AJR Am J Roentgenol; 1987 Feb; 148(2):399-404. PubMed ID: 3492120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism.
    Pouliquen D; Le Jeune JJ; Perdrisot R; Ermias A; Jallet P
    Magn Reson Imaging; 1991; 9(3):275-83. PubMed ID: 1881245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-directed superparamagnetic iron oxide: quantitation of T2 relaxation effects.
    Pouliquen D; Lucet I; Chouly C; Perdrisot R; Le Jeune JJ; Jallet P
    Magn Reson Imaging; 1993; 11(2):219-28. PubMed ID: 8455432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Magnet resonance spectroscopy of tumor-bearing rat livers: magnetite particles as an aid in volume selection].
    Römer T; Gewiese B; Stiller D; Plötz M; Lawaczeck R; Wolf KJ
    Rofo; 1990 Jul; 153(1):79-84. PubMed ID: 2166318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.